18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO-Reference-Cited by-同舟云学术

18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO

Published:2013-10-03 Issue:11 Volume:54 Page:1862-1868
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Gebhart Geraldine,Gámez Cristina,Holmes Eileen,Robles Javier,Garcia Camilo,Cortés Montserrat,de Azambuja Evandro,Fauria Karine,Van Dooren Veerle,Aktan Gursel,Coccia-Portugal Maria Antonia,Kim Sung-Bae,Vuylsteke Peter,Cure Hervé,Eidtmann Holger,Baselga José,Piccart Martine,Flamen Patrick,Di Cosimo Serena

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference34 articles.

1. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

2. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

3. Biological rationale for HER2/neu (c-erbB2) as a target for monoclonal antibody therapy;Pegram;Semin Oncol.,2000

4. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

5. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials;2024-01-16

2. Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial);npj Breast Cancer;2024-01-06

3. Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response;Journal of Clinical Medicine;2023-12-27

4. ¹⁸F-FDG PET “Metabolic Response” to Neoadjuvant Systemic Therapy for Breast Cancer: Quo Vadis?;Journal of Nuclear Medicine;2023-11

5. Metabolic Positron Emission Tomography in Breast Cancer;PET Clinics;2023-10